Overall, the roles of HMGB1, BRD4 and SOX11 as key regulators in the GRN for contrasting DEGs suggests these genes may be key drivers of associated differential alterations in neuroinflammatory, epigenetic and adult neurogenesis-related processes in neurodegenerative diseases. Here, BRD4 is linked to neurodegenerative disease.